LifeWatch has received 510(k) clearance from the U.S. FDA for its Vital Signs Patch (VSP), the company has announced.

The VSP is an easy-to-use sensor worn on a patient’s upper chest, intended to be used on adult patients in a clinical environment for the continuous, non-invasive monitoring of ECG, Heart Rate, respiration rate, surface temperature, and arterial blood oxygen saturation when prescribed by a physician or other qualified healthcare professional.

Once the VSP is activated and connected with the supporting system, it provides automation and alerts of key vital signs via continuous wireless monitoring.

The device will launch in Q3 2015 and so will the full VSP system.